Volume 25, Number 10—October 2019
Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus
|Sample no.||% GCV
|Endpoint||Potencies vs. sample 4||Potencies vs. sample 16|
*Values derived from endpoint titers or from potencies expressed as relative to standard samples. GCV, geometric coefficient of variation.
1Study participants who contributed data are listed at the end of this article.